MIP Discovery secures significant funding to support development of global rapid response diagnostics

Feb. 1, 2023
Funding received from the Bill & Melinda Gates Foundation for rapid deployment of novel detection reagents to support mass scale testing in low to middle-income countries.

MIP Discovery announced it has secured a significant grant of funds from the Bill & Melinda Gates Foundation. The innovative project will focus on the use of MIP Discovery’s animal/cell free detection reagents as an improvement over antibodies, to quickly enable low-cost, high volume diagnostic tests, for low and middle-income countries during endemic or pandemic outbreaks.

MIP Discovery’s proprietary imprinted polymer technology is able to meet the requirements both for speed and scale of novel recognition reagents. The Company is optimizing processes that will be significantly faster than novel antibody production, which is fundamentally rate limited by biological processes such as cell culture. MIP Discovery aims to reduce current timelines to allow design and scale up of novel detection reagents in under 4 weeks. nanoMIP detection reagents can then be deployed using massively high throughput diagnostic platforms or lateral flow devices. A ‘scale out’ approach will allow MIP Discovery to tackle multiple diagnostic markers at once, whilst still achieving the volumes required for mass scale diagnostics.

Visit MIP Discovery for more news